Tags:

Drug Discovery Stem Cells Human Tissue Samples 3D Cell Culture Clinical Capabilities

The REPROCELL Blog

Research • Reports • Resources

Latest Posts

REPROCELL Advances iPSC Innovation with MSCRF Support

REPROCELL has been awarded the Crystal Award for Innovation by MSCRF, highlighting its advancements in iPSC technology and contributions to regenerative medicine.

12 October 2026

Peripheral Blood Mononuclear Cells as Translational Tools in Drug Development

Explore the crucial role of Peripheral Blood Mononuclear Cells in drug development, enhancing immunotherapy, biomarker discovery, and personalized medicine.

01 October 2026

More Than Half a Century of Drug Development Attrition: Why Better Human-Relevant Models Are Needed

Explore the urgent need for human-relevant models in drug development to reduce high clinical attrition rates and improve patient outcomes.

03 September 2026

Scaling iPSC Manufacturing: From Cell Line Development to Clinical-Production

Learn how to scale iPSC manufacturing from clinical cell line development and gene editing to GMP cell banking and bioreactor expansion.

27 August 2026

Why PBMCs matter in gene and cell therapies

Explore the vital role of PBMCs in gene therapy and translational research, highlighting their importance in understanding immune responses and treatment efficacy.

23 July 2026

Featured Posts

Featured

Why mRNA Reprogramming Is the Key to Safer and Faster iPSC Generation?

Discover how mRNA reprogramming enhances the safety, efficiency, and scalability of iPSC generation for therapeutic applications. Explore REPROCELL's innovative technologies and services.

Featured

How human fresh tissue models are helping RCD405 achieve regulatory approval

Discover how Arcede Pharma recently used human tissue testing to generate preclinical efficacy data for their compound RCD405.

Featured

How to isolate PBMCs from whole blood using density gradient centrifugation

Find out how to isolate PBMCs from whole blood samples using density gradient centrifugation a.k.a. the Ficoll Overlay method.

Featured

Streamlining PBMC Processing for Reliable Results in Multi-Site Clinical Trials: Key Challenges and Solutions

Explore the challenges and solutions in PBMC processing for multi-site clinical trials, ensuring reliable results and data integrity for research success.

Featured

AI-Designed CRISPR Enables Hypoimmune iPSC Engineering for Off-the-Shelf Cell Therapy

REPROCELL's StemEdit platform enables the creation of hypoimmune iPSCs for scalable off-the-shelf cell therapies, reducing immune rejection and enhancing patient access.